Search - tctmd.com

Displaying 1 - 20 of 238

Sort: Relevancy | Date

News Conference News ACC 2026

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

Michael O'Riordan

April 01, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

Caitlin E. Cox

April 01, 2026

News Daily News

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Yael L. Maxwell

March 16, 2026

News Daily News

Digital Data May Sway Intensive BP Treatment in the Elderly

L.A. McKeown

March 09, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

Michael O'Riordan

March 02, 2026

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

L.A. McKeown

February 06, 2026

News Conference News ISC 2026

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

Todd Neale

February 06, 2026

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

L.A. McKeown

October 09, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Todd Neale

June 06, 2025

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Conference News EAS 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Yael L. Maxwell

May 08, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown

February 14, 2025

Advertisement

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

TCTMD’s Top 10 Most Popular Stories for March 2026

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Digital Data May Sway Intensive BP Treatment in the Elderly

TCTMD’s Top 10 Most Popular Stories for February 2026

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

December 2025 Dispatch for the CV Team

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

TCTMD’s Top 10 Most Popular Stories for April 2025

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content